BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Condition(s):Ovarian CancerLast Updated:March 12, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Ovarian CancerLast Updated:March 12, 2024Not yet recruiting
Condition(s):Ovarian NeoplasmsLast Updated:February 21, 2023Completed
Condition(s):Ovarian Cancer; Ovarian Neoplasms; Ovary Cyst; Ovary DiseaseLast Updated:May 10, 2023Recruiting
Condition(s):Ovarian CancerLast Updated:March 24, 2021Unknown status
Condition(s):Ovarian NeoplasmsLast Updated:September 27, 2022Completed
Condition(s):Ovarian NeoplasmsLast Updated:September 25, 2023Active, not recruiting
Condition(s):Patient Reported Outcome Measures; Ovarian NeoplasmsLast Updated:May 5, 2022Recruiting
Condition(s):Ovarian CancerLast Updated:March 19, 2024Not yet recruiting
Condition(s):Ovarian CancerLast Updated:November 7, 2023Recruiting
Condition(s):Ovarian NeoplasmsLast Updated:July 21, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.